Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human PLK2 Stable Cell Line

    [CAT#: S01YF-1023-PY78]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1222-KX458 Magic™ Human PLK2 in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;T98G;A172
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Cancer Research
    Related Diseases
    Hereditary Breast Ovarian Cancer Syndrome; Epilepsy, Familial Temporal Lobe, 2
    Gene ID
    Human:10769
    UniProt ID
    Human:Q9NYY3

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    PLK2, or Polo-like kinase 2, has various applications in different fields. In liver cancer, PLK2 is affected by miR-3200, a noncoding RNA, and is involved in the growth of liver cancer cells by enhancing Rab7A. PLK2 also plays a role in synaptic destabilization in the brain, where it disrupts N-cadherin adhesion complexes during homeostatic adaptation to hyperexcitation. Additionally, PLK2 is implicated in the aggregation and cytotoxicity of α-synuclein, a protein associated with neurodegenerative disorders. It phosphorylates α-synuclein at multiple serine residues, leading to increased aggregation potential and toxicity. In non-small cell lung cancer, PLK2 is part of a pathway that can be targeted to overcome acquired resistance to EGFR-TKIs. Finally, PLK2 is involved in the expression of genes regulating cell division in porcine follicular granulosa cells, affecting processes related to ovarian follicular growth and ovulation.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human PLK2 Stable Cell Line (S01YF-1023-PY78). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Casey Davis (Verified Customer)

    What is the significance of PLK2 in glioblastoma prognosis? Jan 28 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    PLK2 may serve as a novel biomarker for the prognosis of glioblastoma and a potential target for treatment. Jan 28 2022

    chat Casey Jones (Verified Customer)

    How does PLK2 affect kidney injury? Feb 12 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    PLK2 acts as an anti-oxidative and anti-inflammatory regulator, protecting kidney cells from toxicants and stresses. Feb 12 2021

    Published Data

    Fig.1 Glioma cell growth was influenced by the expression of PLK2.

    Cell proliferation was assessed using a CCK8 assay, and a significant decrease in cell viability was observed in cells treated with shPLK2-1 and shPLK2-2 (P < 0.001).

    Ref: Cao, Fang, et al. "Knocking down of Polo-like kinase 2 inhibits cell proliferation and induced cell apoptosis in human glioma cells." Life Sciences 270 (2021): 119084.

    Pubmed: 33482186

    DOI: 10.1016/j.lfs.2021.119084

    Research Highlights

    Song, Shuting. et al. "miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A." Non-coding RNA research, 2023.
    Recent research suggests that miR-3200 may play a significant role in tumorigenesis, but its specific impact on human hepatocarcinogenesis remains unknown. The current study aims to shed light on this subject by providing evidence that miR-3200 promotes the growth of liver cancer cells. This finding highlights the potential of miR-3200 as a target for therapeutic interventions in liver cancer treatment.
    Song, Shuting. et al. "miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A." Non-coding RNA research, 2023.
    Pubmed: 37860266   DOI: 10.1016/j.ncrna.2023.10.005

    Abdel-Ghani, Mai. et al. "Plk2 promotes synaptic destabilization through disruption of N-cadherin adhesion complexes during homeostatic adaptation to hyperexcitation." Journal of neurochemistry, 2023.
    The process of synaptogenesis in the brain is largely regulated by specific synaptic cellular adhesion molecules (CAMs) like N-cadherin and amyloid precursor protein (APP). While N-cadherin is crucial for synapse development and plasticity, its role in synapse dismantling is not fully understood. Neurodegenerative diseases and excessive neuronal activity can lead to weakening and loss of synapses. Recent research has shown that Polo-like kinase 2 (Plk2) phosphorylates both N-cadherin and APP, resulting in their breakdown and impairment of synaptic structure. This disruption of N-cadherin's adhesive properties destabilizes excitatory synapses and contributes to their eventual elimination. This mechanism has potential implications for cognitive disorders associated with abnormal synapse loss.
    Abdel-Ghani, Mai. et al. "Plk2 promotes synaptic destabilization through disruption of N-cadherin adhesion complexes during homeostatic adaptation to hyperexcitation." Journal of neurochemistry, 2023.
    Pubmed: 37654026   DOI: 10.1111/jnc.15948

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare